Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study

Cited by (579)

Items 201–300 of 579

1. Characteristics and outcomes of COVID-19 infection in 45 patients with breast cancer: A multi-center retrospective study in Hubei, China
   Jielin Wei, Mengjiao Wu, Jing Liu, Xu Wang, Peng‐Fei Xia, Ling Peng, Yu Huang, Cuiwei Liu, Zihan Xia, Chuang Chen et al. · 2021 · The Breast
2. Impact of Timing of Tocilizumab Use in Hospitalized Patients With SARS-CoV-2 Infection
   Anup Kumar Singh, Margarita Oks, Gregg A. Husk, Samuel Paul Dechario, Bushra A. Mina, Kanwaljit Singh, Linda Kirschenbaum, Charles Carpati, Omar K. Mahmoud, Nader Ishak Gabra et al. · 2021 · Respiratory Care
3. Clinical profile and outcomes of COVID-19 infection during the first wave in children with hematological illnesses and cancer
   Swati Bhayana, Manas Kalra, Pallavi Sachdeva, Anupam Sachdeva · 2021 · Cancer Research Statistics and Treatment
4. COVID-19 and Cancer: Special Considerations for Patients Receiving Immunotherapy and Immunosuppressive Cancer Therapies
   Jason D. Goldman, Michael A. Gonzalez, Maria Madeleine Rüthrich, Elad Sharon, Marie von Lilienfeld‐Toal · 2022 · American Society of Clinical Oncology Educational Book
5. Mortality in patients with cancer and SARS-CoV-2 infection: Results from the Argentinean Network of Hospital-Based Cancer Registries
   Gisel Lorena Fattore, Natalia Silvana Aráoz Olivos, José Enrique Carrizo Olalla, Lara Gomez, Agustina Flamenco Marucco, María Paz Rojas Mena · 2022 · Cancer Epidemiology
6. Personalized (N-of-1) Trials for Patient-Centered Treatments of Multimorbidity
   Jerry M. Suls, Catherine M. Alfano, Christina Yap · 2022 · Harvard Data Science Review
7. Clinical outcomes in cancer patients with COVID ‐19
   Amelia Sawyers, Margaret M. Chou, Paul M. Johannet, Nicholas Gulati, Yingzhi Qian, Judy Zhong, Iman Osman · 2021 · Cancer Reports
8. Predictors of clinical evolution of SARS‐CoV‐2 infection in hematological patients: A systematic review and meta‐analysis
   Elena Carrara, Elisa Razzaboni, Anna Maria Azzini, Maria Elena De Rui, Mariana Nunes Pinho Guedes, Anna Górska, Maddalena Giannella, Linda Bussini, Michele Bartoletti, Federica Arbizzani et al. · 2022 · Hematological Oncology
9. SARS-CoV-2 nucleocapsid protein interaction with YBX1 displays oncolytic properties through PKM mRNA destabilization
   Xin Chen, Baohong Jiang, Yu Gu, Zhaoyang Yue, Ying Liu, Zhiwei Lei, Ge Hoa Yang, Minhua Deng, Xuelong Zhang, Zhen Luo et al. · 2024 · Molecular Cancer
10. Integration of SERS with cutting-edge technologies for enhanced detection of drug-resistant microorganisms and optimized drug susceptibility testing
    Shuo Zheng, Qian Wang, Tuotuo Zhang, Xinwei Zhang, Hanying Wang, Nanke Cheng, Yuhan Gao, Zhuoran Hu, Sheng Qiu, Lihui Zhao et al. · 2025 · Coordination Chemistry Reviews
11. What Proportion of Patients with Bone and Soft Tissue Tumors Contracted Coronavirus-19 and Died From Surgical Procedures During the Initial Period of the COVID-19 Pandemic? Results From the Multicenter British Orthopaedic Oncology Society Observational Study
    Raja Bhaskara Rajasekaran, Robert U. Ashford, Thomas D. A. Cosker, Jonathan Daniel Stevenson, Lee Marcus Jeys, Rob C. Pollock, Kenneth Samora Rankin, Paul Cool, James T. Patton, Duncan Whitwell et al. · 2020 · Clinical Orthopaedics and Related Research
12. Characteristics and outcomes of patients with cancer and COVID-19: results from a cohort study
    Alexander Höllein, Peter Bojko, Sebastian Schulz, Julia S. Neitz, Oliver J. Stötzer, Rudolf Pihusch, Fariborz Abedinpour, Burkhard Schmidt, Marcus Hentrich · 2021 · Acta Oncologica
13. Impact of anti-cancer therapy on disease severity and mortality in cancer patients with COVID-19: a systematic review and meta-analysis
    Zhixian Lin, Jiangfeng Chen, Sunya Han · 2021 · Expert Review of Anticancer Therapy
14. Impact of COVID‐19 lockdown on routine oncology versus emergency care at a high volume cancer centre
    Christoph Minichsdorfer, Georg Jeryczynski, Christoph Krall, Alina Magdalena Achhorner, Ariane Caraan, Sabina Pasalic, Katharina Reininger, Christina Wagner, Rupert Bartsch, Matthias Preusser et al. · 2021 · European Journal of Clinical Investigation
15. Does prior exposure to immune checkpoint inhibitors treatment affect incidence and mortality of COVID-19 among the cancer patients: The systematic review and meta-analysis
    Yang Liu, Shuo Liu, Yujun Qin, Lei Zhao, Yiliang Li, Chenghui Zhou, Wei Chen · 2021 · International Immunopharmacology
16. Clinical features of Chinese children with COVID‐19 and other viral respiratory infections
    Zhenzhen Zhang, Dapeng Chen, Quanbo Liu, Chuan Gan, Li Jiang, Kun Zhu, Xia‐Yi Zhang, Hongmei Xu, Ailong Huang, Quanxin Long et al. · 2021 · Pediatric Pulmonology
17. Neutralizing antibody responses against SARS‐CoV ‐2 in patients with plasma cell disorders who are on active treatment after two doses of mRNA vaccination
    Al-Ola A. Abdallah, Zahra Mahmoudjafari, Tahani Atieh, Nausheen Ahmed, Wei Cui, Leyla Osman Shune, Meera Mohan, Joseph P. McGuirk, Cassie Remker, Margaret Foss et al. · 2022 · European Journal Of Haematology
18. Cerebrovascular accident in a child with precursor B-cell acute lymphoblastic leukemia and coronavirus disease 2019: a case report
    Hanie Karimi, Roham Sarmadian, Abolfazl Gilani, Pouria Salajegheh, Habibe Nejad Biglari, Mahsa Gholizadeh · 2022 · Journal of Medical Case Reports
19. Identifying the Risk Factors for Mortality in Patients with Cancer and COVID-19 in Hamadan, the West of Iran
    Malihe Safari, Javad Faradmal, Saeid Bashirian, Ali Reza Soltanian, Salman Khazaei, Ghodratollah Roshanaei · 2021 · Journal of Gastrointestinal Cancer
20. Analysis of Survival of Patients Hospitalized with COVID-19 in Espírito Santo, Brazil
    Juliana Rodrigues Tovar Garbin, Franciéle Marabotti Costa Leite, Luís Carlos Lopes‐Júnior, Cristiano Soares da Silva Dell’Antonio, Larissa Soares Dell’Antonio, Ana Paula Brioschi dos Santos · 2022 · International Journal of Environmental Research and Public Health
21. Modulating mitochondrial dynamics ameliorates left ventricular dysfunction by suppressing diverse cell death pathways after diabetic cardiomyopathy
    Fu-Min Zhi, Xiang-Yi Pu, Wei Wei, Li Liu, Chun-Yan Liu, Ye Chen, Xing Chang, Hong-Tao Xu · 2024 · International Journal of Medical Sciences
22. Prospective Medicinal Plants and Their Phytochemicals Shielding Autoimmune and Cancer Patients Against the SARS-CoV-2 Pandemic: A Special Focus on Matcha
    Caroline Joseph Kiriacos, Monika Rafik Khedr, Miray Tadros, Rana Ahmed Youness · 2022 · Frontiers in Oncology
23. SARS-CoV-2 primary and breakthrough infections in patients with cancer: Implications for patient care
    Lindsey Wang, William Jiaen Wang, Rong Xu, Nathan A. Berger · 2022 · Best Practice & Research Clinical Haematology
24. Global reported impacts of COVID ‐19 on lymphoma patients and the emerging clinical management approaches in response to the ongoing pandemic
    Esther K. Elliott, Robert Hensen, Larisa Margaret Haupt, Lyn Robyn Griffiths · 2023 · European Journal Of Haematology
25. The Impact of COVID-19 Pandemic on Lung Cancer Community
    Licun Wu, Chengke Zhang, Xiaogang Zhao · 2021 · World Journal of Oncology
26. Characteristics and outcomes of cancer patients with covid-19 at a safety-net hospital
    Muhammet Özer, Suleyman Yasin Goksu, Mohammed Mahdi, Neel Gandhi · 2021 · Cancer Treatment and Research Communications
27. Hyperthermia ablation combined with transarterial chemoembolization versus monotherapy for hepatocellular carcinoma: A systematic review and meta‐analysis
    Zheng Li, Qiang Li, Xiaohu Wang, Wei‐Qiang Chen, Xiaodong Jin, Xinguo Liu, Fei Ye, Zhongying Dai, Xiaogang Zheng, Ping Li et al. · 2021 · Cancer Medicine
28. Proportion of hematological cancer patients with SARS-CoV-2 infection during the COVID-19 pandemic: A systematic review and meta-analysis
    Mohammadali Jafari, Seyed Alireza Dastgheib, Farzad Ferdosian, Hamid Mirjalili, Hossein Aarafi, Mahmood Noorishadkam, Mahta Mazaheri, Hossein Neámatzadeh · 2021 · Hematology Transfusion and Cell Therapy
29. “Outcomes of COVID-19 infection in patients with hematological malignancies- A multicenter analysis from Pakistan”
    Adeeba Zaki, Salman Muhammad Soomar, Danish Hasan Khan, Hasan Shaharyar Sheikh, Raheel Iftikhar, Ayaz Mir, Zeba Aziz, Khadija Bano, Hafsa Naseer, Qamar Un Nisa Chaudhry et al. · 2022 · PLoS ONE
30. Two in one: Overlapping CT findings of COVID-19 and underlying lung diseases
    Gamze Durhan, Selin Ardalı Düzgün, Yusuf Baytar, Meltem Gülsün Akpınar, Figen Demirkazık, Orhan Macit Arıyürek · 2022 · Clinical Imaging
31. Impact of coronavirus disease 2019 on lung cancer patients: A meta-analysis
    Linlin Wang, Ye Wang, Xianbin Cheng, Xingzhao Li, Jun Li · 2022 · Translational Oncology
32. Clinical research progress of callisperes® of drug-loaded microsphere arterial chemoembolisation in the treatment of solid tumors
    Qin Wang, Lujian Zhu, Qiyue Sheng · 2024 · Discover Oncology
33. Clinical Characteristics of COVID-19-Infected Cancer Patients in Pakistan: Differences Between Survivors and Non-Survivors
    Kashif Asghar, Muhammad Abu Bakar, Muhammad Junaid Akram, Asim V. Farooq, Kashif Siddique, Iftikhar Ali Rana, Jamshed Ali, Muhammad Usman Rashid, Ashraf Ali Khan, Asif Loya · 2021 · Frontiers in Oncology
34. Colorectal cancer in patients with SARS-CoV-2: a systematic review and meta-analysis
    Saad Alhumaid, Abbas Saleh Al Mutair, Jawad S. Busubaih, Nourah Al Dossary, Murtadha Alsuliman, Sarah A. Baltyour, Ibrahim Alissa, Hassan I. Al Hassar, Noor A. Al Aithan, Hani A. Albassri et al. · 2022 · Infectious Agents and Cancer
35. Current global research landscape on COVID-19 and cancer: Bibliometric and visualization analysis
    Sa’ed H. Zyoud, Amer A. Koni, Samah W. Al‐Jabi, Riad Ahmad Amer, Muna H. Shakhshir, Rand Al Subu, Husam T. Salameh, Razan Y. Odeh, Sultan Musleh, Faris Abushamma et al. · 2022 · World Journal of Clinical Oncology
36. Prevalence and Clinical Impact of SARS-CoV-2 Silent Carriers Among Actively Treated Patients with Cancer During the COVID-19 Pandemic
    Alberto Zambelli, Lorenzo Chiudinelli, Vittoria Fotia, Giorgia Negrini, Tommaso Bosetti, Annapaola Callegaro, Andrea Di Croce, Elena Rota Caremoli, Cecilia Moro, Laura Milesi et al. · 2020 · The Oncologist
37. Chemotherapy During Active SARS-CoV2 Infection: A Case Report and Review of the Literature
    Krzysztof Woźniak, Wojciech Sachs, Piotr Boguradzki, Grzegorz Władysław Basak, Rafał Stec · 2021 · Frontiers in Oncology
38. Impact of COVID-19 on Patients with Cancer Receiving Immune Checkpoint Inhibitors
    Ai‐Tram N. Bui, Kevin Tyan, Anita Giobbie‐Hurder, Isaac A. Klein, Michael P. Manos, Leyre Zubiri, Kerry Lynn Reynolds, Shilpa Grover, Gerald L. Weinhouse, Patrick Alexander Ott et al. · 2021 · Journal of Immunotherapy and Precision Oncology
39. Lessons Learned in Managing Patients with Colorectal Cancer During the COVID-19 Pandemic
    Reetu Mukherji, John Lindsay Marshall · 2021 · Current Treatment Options in Oncology
40. Severe Type of COVID-19: Pathogenesis, Warning Indicators and Treatment
    Ke Shi, Yao Liu, Qun Zhang, Chongping Ran, Jie Hou, Yi Zhang, Xianbo Wang · 2021 · Chinese Journal of Integrative Medicine
41. COVID-19 Pandemic Impact on Surgical Treatment Methods for Early-Stage Cervical Cancer: A Population-Based Study in Romania
    Alin Popescu, Marius Lucian Craina, Ștelian Pantea, Cătălin Alexandru Pîrvu, Daniela Radu, Iosif Marincu, Felix Bratosin, Iulia Georgiana Bogdan, Samer Hosin, Cosmin Cîtu et al. · 2022 · Healthcare
42. COVID-19 and Its Impact on Upper Gastrointestinal (GI) Cancer Management
    Shalini Fernando, Mesel Veli, Borzoueh Mohammadi, Andrew Millar, Khurum Hayat Khan · 2021 · Cancers
43. Impact of Underlying Comorbidities on Mortality in SARS-COV-2 Infected Cancer Patients: A Systematic Review and Meta-Analysis
    Harmanjeet Kaur, Jarnail Singh Thakur, Ronika Paika, Shailesh Advani · 2021 · Asian Pacific Journal of Cancer Prevention
44. ANMCO POSITION PAPER: cardio-oncology in the COVID era (CO and CO)
    Irma Bisceglia, Domenico Gabrielli, Maria Laura Canale, Giuseppina Gallucci, Iris Parrini, Fabio Maria Turazza, Giulia Russo, Nicola Maurea, Vincenzo Quagliariello, Chiara Lestuzzi et al. · 2021 · European Heart Journal Supplements
45. Investigation of the Effect of Comorbidity on Mortality in Patients with COVID-19: A Systematic Review and Meta-Analysis
    2021 · Biointerface Research in Applied Chemistry
46. Silver nanocluster-based ratiometric fluorescence sensors for X-ray dose detection
    Chengfang Zhang, Yuanyuan Yang, Danni Qin, Rui Hu, Liang Hu · 2024 · Talanta
47. Factors associated with SARS-CoV-2 infection and outcome in patients with solid tumors or hematological malignancies: a single-center study
    Anouk Goudsmit, Edouard Cubilier, Anne‐Pascale Meert, Philippe Georges Aftimos, Konstantinos Stathopoulos, Chloé Spilleboudt, Angela Loizidou · 2021 · Supportive Care in Cancer
48. Impact of Cancer History on Outcomes Among Hospitalized Patients with COVID-19
    Isaac A. Klein, Shoshana M. Rosenberg, Kerry Lynn Reynolds, Leyre Zubiri, Rachel Pam Greenerger Rosovsky, Andrew J. Piper‐Vallillo, Xin Yuan Gao, Genevieve Marie Boland, Aditya Bardia, Rachel Gaither et al. · 2021 · The Oncologist
49. Mortalidad por COVID-19 asociada a comorbilidades en pacientes del Instituto Salvadoreño del Seguro Social
    Víctor David Franco Escobar, Luis Morales Chorro, Rafael Baltrons Orellana, Carlos Romeo Rodríguez, Oscar Urbina, Claudia López de Blanco · 2021 · ALERTA Revista Científica del Instituto Nacional de Salud
50. Risk factors for excess deaths during lockdown among older users of secondary care mental health services without confirmed COVID‐19: A retrospective cohort study
    Shanquan Chen, Peter Brian Jones, Benjamin R. Underwood, Emilio Fernández-Egea, Pei Qin, Jonathan R. Lewis, Rudolf N. Cardinal · 2021 · International Journal of Geriatric Psychiatry
51. Cancer management during the COVID-19 world pandemic
    Navid Sobhani, Giuseppina Mondani, Giandomenico Roviello, Martina Catalano, Marianna Sirico, Alberto D’Angelo, Bruna Scaggiante, Daniele Generali · 2023 · Cancer Immunology Immunotherapy
52. Routine use of immunosuppressants is associated with mortality in hospitalised patients with COVID-19
    Phyo Kyaw Myint, Ben Carter, Fenella Barlow-Pay, Roxanna Short, Alice Einarsson, Eilidh Bruce, Kathryn L. McCarthy, Alessia Verduri, Jemima Collins, James Hesford et al. · 2021 · Therapeutic Advances in Drug Safety
53. Challenges and opportunities for ovarian cancer management in the epidemic of Covid-19: lessons learned from Wuhan, China
    Zhilan Chen, Chun Zhang, Jiu Yin, Xin Xin, Hemei Li, Ya‐Pei Wang, Benjamin K. Tsang, Qinghua Zhang · 2021 · Journal of Ovarian Research
54. B‐cell lymphoma‐2 family proteins‐activated proteases as potential therapeutic targets for influenza A virus and severe acute respiratory syndrome coronavirus‐2: Killing two birds with one stone?
    Sourabh Soni, Yohannes Afework Mebratu · 2022 · Reviews in Medical Virology
55. Effect of antitumor therapy on cancer patients infected by SARS‐CoV‐2: A systematic review and meta‐analysis
    Piao Li, Lingling Li, Shennan Wang, Yu Liu, Li Zhou, Shu Xia · 2021 · Cancer Medicine
56. Low mortality of people living with diabetes mellitus diagnosed with COVID-19 and managed at a field hospital in Western Cape Province, South Africa
    J-N Van der Westhuizen, Nadia Hussey, Margaretha Maria Zietsman, N Salduker, Kathryn Manning, Joel Alex Dave, Bojana Bulajic, Tasleem Ras · 2021 · South African Medical Journal
57. Challenges of cancer immunotherapy and chemotherapy during the COVID-19 pandemic
    Mobina Fathi, Kimia Ghazi Vakili, Kimia Jazi, Mohammad Amin Sadeghi, Mohammadreza Hajiesmaeili, Ashraf Mohamadkhani, Mostafa Rezaei–Tavirani, Arian Tavasol · 2021 · Tumori Journal
58. Learning From Biological and Computational Machines: Importance of SARS-CoV-2 Genomic Surveillance, Mutations and Risk Stratification
    Shikha Bhat, Anuradha Pandey, Akshay Kanakan, Ranjeet Maurya, Janani Srinivasa Vasudevan, Priti Devi, Partha Chattopadhyay, Shimpa R. Sharma, Rajesh J. Khyalappa, Meghnad G. Joshi et al. · 2021 · Frontiers in Cellular and Infection Microbiology
59. Complete remission of Hodgkin Lymphoma after a concurrent infection with COVID-19: systematic review and meta-analysis
    Nasser Ghaly Yousif · 2022 · Muthanna Medical Journal
60. Clinical and inflammation marker features of cancer patients with COVID-19: data of Istanbul, Turkey multicenter cancer patients (2020–2022)
    Çağlar Ünal, Gülşah Tunçer, Betül Çopur, Kezban Nur Pilancı, Kerem Okutur, Kanay Yararbaş, Özkan Alan, Abdullah Sakin, Melih Şimşek, İpek Özönder Ünal et al. · 2023 · Current Medical Research and Opinion
61. The demographic characteristics, prognosis, and relationship with cancer subtypes of hospitalized COVID‐19 patients with malignancy: A single‐center experience
    Ezgi Değerli, Sümeyra Derin, Kerem Oruç, Nilay Şengül Samancı, Şahin Bedir, Emir Çelik, Nihan Şentürk Öztaş, Gülin Alkan, Fuat Hulusi Demirelli, Nebi Serkan Demirci · 2021 · Journal of Medical Virology
62. Business as unusual: medical oncology services adapt and deliver during COVID ‐19
    Avraham Travers, Kim Adler, Gillian Blanchard, Tony Bonaventura, Julie A. Charlton, Fiona Lee Day, Laura Healey, Sang Kim, Janine Margaret Lombard, Girish Mallesara et al. · 2021 · Internal Medicine Journal
63. Safety and Feasibility of Lung Cancer Surgery under the COVID-19 Circumstance
    Lawek Berzenji, Leonie Vercauteren, Suresh Krishan Yogeswaran, Patrick Lauwers, Jeroen M. Hendriks, Paul Emile Van Schil · 2022 · Cancers
64. Challenges and recommendations for cancer care in the COVID-19 pandemic
    Jianbo Tian, Xiaoping Miao · 2020 · Cancer Biology and Medicine
65. Outcomes and inflammation changes in different types of immunocompromised patients with critically ill COVID-19 admitted to ICU: a national multicenter study
    Chunyan Li, Hangyong He, Yuqiong Wang, Linna Huang, Ziying Chen, Qi Zhang, Ying Cai, Tianshu Zhai, Xiaojing Wu, Qingyuan Zhan · 2024 · BMC Pulmonary Medicine
66. Teleconsulta no Contexto da Covid-19: Experiência de uma Equipe em Cuidados Paliativos
    Andréa Augusta Castro, Ana Cláudia Santos Chazan, Caroline Peixoto dos Santos, Elza Maria Bayer Candal, Luiz Fernando Chazan, PATRÍCIA CRISTINA DOS SANTOS FERREIRA · 2020 · Revista Brasileira de Educação Médica
67. Mortality from COVID-19 in patients with lung cancer
    Amit A. Kulkarni, Grace V. Wilson, Naomi Fujioka, Manish R. Patel · 2021 · Journal of Cancer Metastasis and Treatment
68. Preinfection laboratory parameters may predict COVID‐19 severity in tumor patients
    Alexander Kiani, Romina Roesch, Clemens‐Martin Wendtner, Frank Kullmann, Thomas Kubin, Thomas Südhoff, Marinela Augustin, Markus Andreas Schaich, Clemens Müller‐Naendrup, Gerald Illerhaus et al. · 2021 · Cancer Medicine
69. The Impact of COVID-19 Pandemic in Portuguese Cancer Patients: A Retrospective Study
    Áurea Lima, Hugo Manuel Lopes de Sousa, Amanda Nobre, Ana Luisa Faria, Manuela Machado · 2021 · International Journal of Environmental Research and Public Health
70. Seropositivity and neutralising antibodies at six months after BNT162b2 vaccination in patients with solid tumours
    Ofer Margalit, Einat Shacham‐Shmueli, Amit Itay, Raanan Berger, Sharon Halperin, Menucha Jurkowicz, Einav Gal Levin, Liraz Olmer, Gili Regev‐Yochay, Yaniv Lustig et al. · 2022 · European Journal of Cancer
71. Delirium in Critically Ill Cancer Patients With COVID-19
    Christian Bjerre-Real, Vikram Dhawan, Mehak Sharma, Kenneth Seier, Kay See Tan, Konstantina Matsoukas, Molly Maloy, Louis P. Voigt, Yesne Alici, Sanjay Chawla · 2022 · Journal of the Academy of Consultation-Liaison Psychiatry
72. Bio‐ethical issues in oncology during the first wave of the COVID‐19 epidemic: A qualitative study in a French hospital
    Henri‐Corto Stoeklé, Laure Ladrat, Térence Landrin, Philippe Beuzeboc, Christian Hervé · 2022 · Journal of Evaluation in Clinical Practice
73. COVID-19 Diagnosis and Risk of Death Among Adults With Cancer in Indiana: Retrospective Cohort Study
    Nimish R. Valvi, Hetvee Patel, Giorgos Bakoyannis, David Andrew Haggstrom, Sanjay Mohanty, Brian Edward Dixon · 2022 · JMIR Cancer
74. Factors influencing COVID-19 mortality among cancer patients: A Brazilian multi-institutional study
    Jessé Lopes da Silva, Bruno Santos Wance de Souza, Lucas Zanetti de Albuquerque, Sabina Bandeira Aleixo, Gilmara Anne da Silva Resende, Daniela Galvão Barros de Oliveira, Emerson Neves dos Santos, Angélica Nogueira‐Rodrigues, Renan Orsati Clara, Maria de Fátima Dias Gauí et al. · 2023 · PLoS ONE
75. COVID-19 in Immunocompromised Cancer Patients: A Case Series and Review of the Literature
    Raj H. Patel, Rachana Vanaparthy, John Norman Greene · 2021 · Cancer Control
76. Home Se-Cure: A Home Care Service for Cancer Patients during the COVID-19 Pandemic
    Tania Buttiron Webber, Silvia Giuliano, Carlotta Patrone, Irene Maria Briata, Maria Franconeri, Francesca Marceca, Monica Magnani, Fortuna Paciolla, Nicoletta Provinciali, Carlotta Defferrari et al. · 2021 · International Journal of Environmental Research and Public Health
77. Whole-Genome Sequencing of SARS-CoV-2 Infection in a Cluster of Immunocompromised Children in Indonesia
    Nina Dwi Putri, Edison Johar, Yora Permata Dewi, Nuri Dyah Indrasari, Dewi Wulandari, Merci Monica Pasaribu, Teny Tjitra Sari, Fitri Prima Cakti, Madeline Ramdhani Jasin, Tartila Tartila et al. · 2022 · Frontiers in Medicine
78. Covid-19 in pediatric hematology-oncology and stem cell transplant patients –The spectrum of illness, complications and comparison of first two waves
    Swati Bhayana, Manas Kalra, Anupam Sachdeva · 2022 · Pediatric Hematology Oncology Journal
79. Continuous care needs in patients with cancer receiving chemotherapy during the recent omicron wave of COVID-19 in Shanghai: A qualitative study
    Jie Zhang, Cai‐Feng Wang, Lei Huang, Jun Zhang · 2023 · Frontiers in Psychology
80. Real-world outcomes in thoracic cancer patients with severe Acute respiratory syndrome Coronavirus 2 (COVID-19): Single UK institution experience
    Wanyuan Cui, Nadia Yousaf, Jaishree Bhosle, Anna Rachel Minchom, Andrew Gordon Nicholson, Merina Ahmed, Fiona McDonald, Imogen Locke, Richard Lee, Mary E.R. O'Brien et al. · 2020 · Cancer Treatment and Research Communications
81. Ferroptosis in viral infection: a potential therapeutic target
    Liqiong Ding · 2024 · Future Microbiology
82. Vulnerable Groups and Travel Health Considerations
    Sarah L. McGuinness, Robert J. Steffen · 2021 · Springer eBooks
83. Cancer treatment in the coronavirus disease pandemic
    Jia‐Tao Zhang, Wen‐Zhao Zhong, Yi-Long Lung Cancer Wu · 2020 · Lung Cancer
84. Meeting the Challenges in Cancer Care Management During the SARS-Cov-2 Pandemic: A Retrospective Analysis
    Marika Anna Rasschaert, Pieterjan Vanclooster, Laura Depauw, Tim Mertens, Ella Roelant, Elke Coenen, Sébastien Anguille, Annelies Janssens, Peter A. van Dam, Marc Peeters · 2021 · Cancer Control
85. Comparison of characteristics and laboratory tests of COVID-19 hematological patients from France and Brazil during the pre-vaccination period: identification of prognostic profiles for survival
    Lilith Faucheux, Lucas Bassolli de Oliveira Alves, Sylvie Chevret, Vanderson Rocha · 2022 · Hematology Transfusion and Cell Therapy
86. Clinical characteristics and risk factors associated with nosocomial COVID-19 infection in patients with hematological disorders in Japan
    Shin Ohara, Takayuki Fujii, Shiro Ide, Tomoyuki Uchida, Morihiro Inoue, Masao Hagaihara · 2021 · International Journal of Hematology
87. Impact of COVID-19 on medical treatment patterns in gynecologic oncology: a MITO group survey
    Raffaella Cioffi, Giulia Sabetta, Emanuela Rabaiotti, Alice Bergamini, Luca Bocciolone, Giorgio Candotti, Massimo Candiani, Giorgio Valabrega, Giorgia Mangili, Sandro Pignata et al. · 2021 · International Journal of Gynecological Cancer
88. Clinical Characteristics of Cancer Patients With COVID-19: A Retrospective Multicentric Study in 19 Hospitals Within Hubei, China
    Deliang Guo, Haitao Wang, Qian Zhu, Yufeng Yuan · 2021 · Frontiers in Medicine
89. COVID-19-related mortality in cancer patients in an Irish setting
    Anna Linehan, Orla M. Fitzpatrick, Darren Cowzer, Maeve Hennessy, Zac L. Coyne, Amy Nolan, Maeve Clarke, Róisín Ní Dhónaill, Bryan T. Hennessy, Patrick Glyn Morris et al. · 2021 · Irish Journal of Medical Science (1971 -)
90. Mortality rate in cancer patients with COVID-19: meta-analysis data
    Nasser Ghaly Yousif · 2021 · American Journal of BioMedicine
91. Enhanced X-ray Dose Response of Radio-fluorescent Hydrogels Enabled by Persulfate Salts
    Danni Qin, Yaqi Han, Liang Hu · 2023 · Journal of Fluorescence
92. Determinants of COVID-19 Disease Severity–Lessons from Primary and Secondary Immune Disorders including Cancer
    Antonio Giovanni Solimando, Max Bittrich, Endrit Shahini, Federica Albanese, Georg Fritz, Markus Krebs · 2023 · International Journal of Molecular Sciences
93. Outcomes of diagnosed COVID-19 cancer patients: concerning results of a systematic review
    C. Nahshon, Y. Segev, M. Schmidt, T. Bar-noy, L. Ostrovsky, O. Lavie · 2021 · Journal of Chemotherapy
94. Protein expression of transmembrane protease serine 4 in the gastrointestinal tract and in healthy, cancer, and SARS‑CoV‑2 infected lungs
    Rachel Kerslake, Harpal Singh Randeva, Danny David Jonigk, Christopher Werlein, Jan Lukas Robertus, Periklis Katopodis, Petra Jasker, Demetrios A. Spandidos, Ioannis Kyrou, Emmanouíl Karteris · 2022 · Molecular Medicine Reports
95. Changes in the Management of Malignant Bone Tumors in the COVID-19 Pandemic in Developing Countries
    Vivek Tiwari, Pankaj Kumar Sharma, Venkatesan Sampath Kumar, Rishi Ram Poudel, Sanjay Meena, Roshan Banjara · 2022 · Cureus
96. Re: A systematic review and meta-analysis: The effect of active cancer treatment on severity of COVID-19
    Caifeng Zou, Yuting Huang, Yuchi Ma, Feng Yang, Deliang Fu · 2021 · European Journal of Cancer
97. Poly(N-isopropylacrylamide) Microgel-Based Sensor for Clinical-Level X-ray Dose Measurements
    Li Jiang, Danni Qin, Chengfang Zhang, Jinbin Cui, Xinyue Xu, Rui Hu, Ping Zhang, Liang Hu · 2023 · ACS Applied Polymer Materials
98. Keep Calm and Carry on: Safety, Feasibility and Early Outcomes of Head and Neck Cancer Treatment During the COVID-19 Pandemic
    Sara Walker, Maureen Thomson, Frances Campbell, Lisa Hay, Derek B. Grose, Allan James, Carolynn Lamb, Ioanna Nixon, Stefano Schipani, Christina Wilson et al. · 2021 · Clinical Oncology
99. Comparaison des caractéristiques et des pronostics des patients avec et sans cancer actif hospitalisés pour une infection à SARS-CoV-2
    Charlotte Fenioux, Yves Allenbach, Aurore Vozy, Joe‐Elie Salem, Georgina Maalouf, Matheus Vieira, Alexandre Le Joncour, Olivier Benvéniste, David Saadoun, Corinne Frère et al. · 2021 · Bulletin du Cancer
100. Management of Breast Cancer Patients During the Coronavirus Disease 2019 Pandemic: The Experience From the Epicenter of China, Wuhan
     Jun Zhou, Yuyin Liu, Ming Xu, Mei Li, Shengnan Ruan, Ning Zhang, Pengfei Yi, Qianzhi Chen, Jie Tan · 2021 · Clinical Breast Cancer